[Bayer E 39 or A 139 in two cases of xeroderma pigmentosum].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D014983:Xeroderma Pigmentosum / Q000628:therapy*
D000970:Antineoplastic Agents
CYTOTOXIC DRUGS/therapeutic use; XERODERMA PIGMENTOSUM/therapy
Bayer E 39 bzw. A 139 bei 2 Fällen von Xeroderma pigmentosum.